![]() |
Identifying Interventions To Delay Or Prevent Breast Cancer Recurrences After Tamoxif
An international research team led by Georgetown Lombardi Comprehensive Cancer Center has found biological differences in hormone-receptor positive breast cancer that are linked to the timing of recurrence despite endocrine therapy...
More... |
| All times are GMT -7. The time now is 04:08 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021